Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMAR H IBRAHIM

Allopathic & Osteopathic Physicians Pediatrics Pediatric Gastroenterology

NPI
1427179423
CMS profile
461055
Location
ROCHESTER, MN

General Payments · PY2019–2023

$26,368.82

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$17,782.86

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $13,000.50 5
Travel and Lodging $4,324.56 5
Food and Beverage $457.80 6

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
ALBIREO PHARMA, INC. $11,877.27 6
Mirum Pharmaceuticals, Inc. $5,905.59 10

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,158.74 4
PY2022 $4,427.22 3
PY2023 $17,782.86 16

Payment records · PY2023 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20192022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ALBIREO PHARMA, INC. $4,039.00 02/10/2023 Consulting Fee Undisputed 01/23/2026 1056525139 CMS
ALBIREO PHARMA, INC. $1,050.79 04/22/2023 Travel and Lodging Undisputed 01/23/2026 1056527453 CMS
ALBIREO PHARMA, INC. $100.98 04/22/2023 Food and Beverage Undisputed 01/23/2026 1056527460 CMS
ALBIREO PHARMA, INC. $2,019.50 05/19/2023 Consulting Fee Undisputed 01/23/2026 1056525265 CMS
ALBIREO PHARMA, INC. $2,513.00 05/26/2023 Consulting Fee Undisputed 01/23/2026 1056527447 CMS
ALBIREO PHARMA, INC. $2,154.00 08/07/2023 Consulting Fee Undisputed 01/23/2026 1056525361 CMS
Mirum Pharmaceuticals, Inc. $2,275.00 04/29/2023 Consulting Fee Undisputed 01/23/2026 1022983473 CMS
Mirum Pharmaceuticals, Inc. $261.11 04/29/2023 Travel and Lodging Undisputed 01/23/2026 1022983475 CMS
Mirum Pharmaceuticals, Inc. $562.80 04/29/2023 Travel and Lodging Undisputed 01/23/2026 1022983477 CMS
Mirum Pharmaceuticals, Inc. $116.56 04/29/2023 Food and Beverage Undisputed 01/23/2026 1022983481 CMS
Mirum Pharmaceuticals, Inc. $88.49 04/29/2023 Food and Beverage Undisputed 01/23/2026 1022983483 CMS
Mirum Pharmaceuticals, Inc. $102.10 04/29/2023 Food and Beverage Undisputed 01/23/2026 1022983487 CMS
Mirum Pharmaceuticals, Inc. $21.67 04/29/2023 Food and Beverage Undisputed 01/23/2026 1022983489 CMS
Mirum Pharmaceuticals, Inc. $28.00 04/29/2023 Food and Beverage Undisputed 01/23/2026 1022983493 CMS
Mirum Pharmaceuticals, Inc. $337.36 04/29/2023 Travel and Lodging Undisputed 01/23/2026 1022983495 CMS
Mirum Pharmaceuticals, Inc. $2,112.50 04/29/2023 Travel and Lodging Undisputed 01/23/2026 1022983499 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2022, 2023
Source files
Dataset page · Bulk file · PY2019 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.